Formulation and in vitro /in Vivo evaluation of Olmesartan medoxomil solid dispersions incorporated E/R trilayer matrix tablets by geomatrix
Keywords:
Olmesartan medoxomil, Trilayer matrix tablet, Guar gum, Geomatrix, In-vivo bioavailability studiesAbstract
An attempt has been made to develop and optimize an novel anti hypertensive trilayered controlled release matrix tablets incorporated with Olmesartan medoxomil solid dispersion prepared by direct compression and consisted of middle active layer with different grades of hydroxypropyl methylcellulose (HPMC), guar gum, ethyl cellulose. Upper and lower layers are prepared with Carnauba wax, guar gum and sodium CMC. The developed drug delivery system provided prolonged drug release rates over a period of 24 h. The release profile of the optimized formulation (HF14) was described by the Zero-order and Higuchi model. In-vivo bioavailability studies were carried out with the optimized formulation (HF14) and reference standard A fair correlation between the dissolution profile and bioavailability for the optimized formulation was observed. The results indicate that the approach used could lead to a successful development of a trilayer extended release formulation up to 24h. These results also demonstrated that the Olmesartan solid dispersion incorporated trilayer tablets shown more bioavailability because of its conversion from crystalline to amorphous form.
References
. Bandelin FJ. Compressed Tablets by Wet granulation. In: Liberman HA, Lachman L, Schwartz JB (editors). Pharmaceutical Dosage Forms: Tablets, 2nd edition, Marcel Dekkar, New York: 2008.
. Ho-Wah H, Robinson J, Lee V. Design and fabrication of oral controlled release drug delivery systems. In: Controlled Drug Delivery. New York: Marcell Dekker Inc; 1987. 373.
. Conte U, Maggi L. Multi-layer tablets as drug delivery devices. Pharm Techn. 1998; 2: 18–25.
. Chidambram N, Porter W, Flood K, Qiu Y. Formulation and characterization of new layered diffusional matrices for zero-order sustained release. J. Control. Release. 1998; 52: 149–158.
. Efentakis M, Politis S. Comparative evaluation of various structures in polymer controlled drug delivery systems and the effect of their morphology and characteristics on drug release. Eur. Polym. J. 2006; 42:1183–1195.
. Conte U, Maggi L, Colombo P, La Manna A. Multi-layered hydrophilic matrices as constant release devices. J Control Rel. 1993; 26: 39-47.
. Yihong Qui, Chidambaram N, Kolette F. Design and evaluation of layered diffusional matrices for zero order sustained-release tablets. J Control Rel. 1998; 51: 123-130.
. Conte U, Maggi L. Modulation from Geomatrix multi-layer matrix tablets containing drugs of different solubility. Biomaterials.1996; 17 (9): 889-896.
. Yihong Q, Kolette F. Design of sustained release matrix system for a highly water soluble compound ABT-089. Int J Pharm. 1997; 157: 46-52.
. Tobyn MJ, Stani forth JN, Baichwal AR, Mc Call TW. Prediction of physical properties of a novel polysaccharide controlled release system. Int J Pharm. 1996; 128: 113-22.
. Praveen Kumar T, Pallavi Y, Deepthi K, Narayana Raju P. Formulation and evaluation of Entacapone sustained release matrix tablets. The Pharma Innovation. 2014; 3(8): 80-88.
. Abhijith S, Amrish C, Formulation and Evaluation of Pulsatile Tablet in Capsule Device. IJPPS. 2013; 5(2): 125-129.
. Balakrishnaiah M, Rama Mohan Gupta V. Enhancement of solubility and dissolution rate of Olmesartan medoxomil by solvent evaporation technique. Der Pharmacia Lettre, 2016; 8 (7): 94-104.
. Jyothirmai B, Satyadev T, Santosh T, Syama Sundar B. Development and Validation of an RP-HPLC Method for the Determination of Olmesartan in Human Plasma. IJRPC. 2014; 4(2): 457-466.
